SOLD OUT!

Earn Up to 2 Hours of CME!

DoubleTree by Hilton, San Juan, Puerto Rico

Pre-Registration is required.

Free of Charge

Program Description

This CME program is designed to enhance neurologists' understanding and management of generalized myasthenia gravis (gMG). Participants will explore how comprehensive assessment of disease burden can inform clinical decision-making and improve individualized care. The program will also examine the pathophysiology of gMG, emphasizing how this guides treatment selection. The limitations of current standard-of-care therapies will also be explored. Participants will review the latest clinical evidence surrounding neonatal Fc receptor (FcRn) inhibitors and CD-19 targeted b-cell therapy, including their role in addressing underlying disease processes and supporting long-term management strategies. By integrating all of these insights, neurologists will be better equipped to optimize patient outcomes and achieve sustained disease control in individuals with gMG.